• Chlorambucil: Optimized Workflows for DNA Crosslinking Assay

  2026-07-27

  Chlorambucil stands apart as a nitrogen mustard alkylating agent, empowering cancer researchers with robust, reproducible DNA crosslinking and selective apoptosis induction. This guide distills recent breakthroughs and expert troubleshooting tips into actionable protocols, enabling precise cytotoxicity assays and translational workflows using APExBIO’s high-purity Chlorambucil.

• Applied Workflows with Clodronate Liposomes for In Vivo Macr

  2026-07-27

  Clodronate Liposomes enable targeted, tissue-specific macrophage clearance in live animal models, revealing immune mechanisms that conventional approaches cannot. This article translates cutting-edge research on phagocytosis and immune aging into practical protocols, troubleshooting insights, and advanced applications for immunology labs.

• Quercetin as a PI3K Inhibitor: Advanced Cancer & Liver Workf

  2026-07-26

  Quercetin's dual role as a PI3K inhibitor and ferroptosis modulator enables advanced, reproducible workflows in cancer and liver injury models. This guide details optimized protocols, troubleshooting strategies, and the latest research insights, empowering scientists to maximize APExBIO's Quercetin for robust preclinical studies.

• Iron Stress Remodels Enterocyte Metabolism and Inflammatory

  2026-07-25

  Navazesh and Ji’s 2025 study demonstrates that iron deficiency and excess, induced via deferiprone and ferric ammonium citrate, distinctly reprogram metabolism and inflammatory signaling in enterocytes. Their metabolomics-guided approach uncovers how iron imbalance impairs proliferation, disrupts key metabolic pathways, and modulates cytokine expression, offering new insights for intestinal and iron-targeted research.

• Cy3 NHS Ester (Non-Sulfonated): Technical Guide for Biomolec

  2026-07-24

  Cy3 NHS ester (non-sulfonated) enables precise fluorescent labeling of amino groups in proteins, peptides, and oligonucleotides, supporting sensitive detection in biomedical imaging workflows. It is optimal for protocols requiring high signal in the orange spectrum and organic co-solvent compatibility. It is not suitable for aqueous-only labeling or for long-term storage in solution.

• Mdivi-1: Selective DRP1 Inhibitor for Advanced Apoptosis Ass

  2026-07-24

  Mdivi-1, a selective DRP1 inhibitor from APExBIO, empowers mitochondrial dynamics research with reproducible control over apoptosis and neuroprotection. Its robust, cell-permeable action and protocol flexibility drive breakthroughs in disease modeling and mechanistic studies.

• Erastin: Precision Ferroptosis Inducer for Advanced Cancer R

  2026-07-23

  Erastin, a gold-standard ferroptosis inducer from APExBIO, empowers selective induction of iron-dependent cell death in RAS/BRAF-mutant tumor models. This guide distills optimized workflows, troubleshooting insights, and translational advances, putting robust oxidative stress assays and combination immunotherapy protocols within reach.

• Cy3 NHS ester (non-sulfonated): Technical Protocol & Best Pr

  2026-07-23

  Cy3 NHS ester (non-sulfonated) provides precise amine-reactive fluorescent labeling of proteins, peptides, and oligonucleotides, with bright orange emission suited for imaging and biochemical quantification. It is appropriate for workflows that tolerate organic co-solvents but should be avoided for highly labile proteins or strictly aqueous protocols.

• AMPK–SQSTM1 Feedback Loop: Dual Antioxidant Activation in Tu

  2026-07-22

  This study reveals a double-positive feedback loop between AMPK and SQSTM1/p62, leading to concurrent activation of AMPK and NFE2L2/NRF2 under metabolic stress. The findings clarify mechanisms of metabolic and antioxidant adaptation in tumor cells, with implications for targeting stress responses in cancer research.

• MG-132 in Metabolic Vulnerability and Redox Control: Beyond

  2026-07-22

  Explore the multifaceted roles of MG-132, a potent proteasome inhibitor, in dissecting cancer cell metabolic vulnerabilities and redox signaling. This article connects advanced mechanistic insights—such as SIRT1-HIF-2a axis targeting—to practical assay design, offering a unique perspective not found in standard MG-132 content.

• Syringin Enhances Sunitinib Sensitivity in RCC via EGFR/PI3K

  2026-07-21

  This study demonstrates that Syringin, a natural bioactive compound, inhibits renal cell carcinoma (RCC) cell viability and proliferation while enhancing apoptosis. Notably, Syringin potentiates sunitinib efficacy in RCC by targeting the EGFR/PI3K/Akt pathway, suggesting a promising strategy for overcoming drug resistance.

• IR-820 (New Indocyanine Green): Precision in In Vivo Imaging

  2026-07-21

  IR-820 (New Indocyanine Green) elevates near-infrared imaging for vascular and tumor research with superior sensitivity and stability. This guide delivers actionable protocols, advanced use-cases, and troubleshooting strategies for maximizing diseased tissue quantification in live animal models.

• AZD1480: Precision JAK2 Inhibitor for Tumor STAT3 Assays

  2026-07-20

  AZD1480 offers exceptional selectivity and potency as a JAK2 inhibitor, enabling rigorous dissection of the JAK2/STAT3 pathway in cancer research. Its workflow-friendly properties and proven synergy in combination assays make it a standout tool for overcoming resistance and unraveling IDO1-induced STAT3 signaling.

• IR-820 (New Indocyanine Green): Advanced In Vivo Imaging Wor

  2026-07-20

  IR-820 (New Indocyanine Green) stands out as a next-generation near-infrared imaging dye, enabling precise quantification of vascular and tumor tissues in living animal models. Its robust signal, compatibility with nanoplatforms, and proven performance in multimodal workflows set new standards for preclinical research.

• Solanesol Technical Guidance: Handling and Research Workflow

  2026-07-19

  Solanesol is a high-purity polyisoprenoid alcohol used in membrane-focused biochemical and pharmaceutical research, including apoptosis, DNA repair, and metabolic enzyme assays. It is not suitable for aqueous or ethanol-based workflows, nor for diagnostic or clinical use.

16321 records 1/1089 page Next 12345 下5页 Last page